The FDA reports a nationwide recall of Hudson RCI Neonatal/Infant Heated Wire Breathing Circuits by Medline Industries.



On July 13, 2026, Medline Industries, LP initiated a nationwide recall of Hudson RCI Neonatal/Infant Heated Wire Breathing Circuits, according to an FDA alert.

The FDA reports that Medline received reports of sporadic failures involving the electrical connector of certain neonatal and infant heated wire breathing circuits. In affected circuits, the heated wire connector (pigtail) at the Neptune humidifier may exhibit discoloration, melting, smoke, burning odor, or other signs of localized thermal damage.

To date, reported events have occurred infrequently relative to the number of devices distributed, with the observed occurrence rate of 0.011% across the distributed population, according to the FDA alert.

The Neptune humidifier is designed with safety features that continually monitor the heated wire circuit and automatically discontinues power to the heated wires when electrical abnormalities are detected. When power to the heated wires is disconnected, respiratory gas flow to the patient continues. The disconnection of power is limited to the heated wire function.

Continued delivery of inadequately heated or unconditioned gas can desiccate and damage the airway epithelium, predisposing the infant to bronchospasm, inspissated secretions, and airway obstruction. Potential continued loss of heated wire function may result in increased circuit condensation (rainout), which can cause inadvertent positive end-expiratory pressure (PEEP), circuit obstruction, or accidental lavage of pooled fluid into the infant’s airway, reduced humidity and delivery of cold, dry gas increases the risk of cold stress, leading to elevated oxygen consumption and worsening respiratory distress.

Consumers who have the affected Hudson RCI Neonatal/Infant Heated Wire Breathing Circuits should stop using and discard the device. Consumers should not return product to Medline.

Medline voluntarily recalled product after thorough investigation of reports received for this issue and notified the FDA of this action. At this time, Medline is not aware of any serious health consequences which have occurred due to use of the device.

Recalled Hudson RCI Neonatal/Infant Heated Wire Breathing Circuits were manufactured on or before July 8, 2026 and distributed from June 28, 2021, to July 31, 2026.

Hudson RCI Neonatal/Infant Heated Wire Breathing Circuits within the scope of the recall can be identified by their product labeling, which includes the name of the device, item number, and manufacturing date. The labeling of products affected by the recall include either a Teleflex or Medline item number, depending on the manufacturing date. Affected products manufactured before January 2024 display a Teleflex label and item number, while products manufactured starting January 2024 or later display a Medline label and item number. Please refer to the example labels below to identify the manufacturing date (red) and item number (blue) on the product label.

Affected Products

Medline Item NumberTeleflex Item Number
HUD78001KIT780-01KIT
HUD78007780-07
HUD78007KIT780-07KIT
HUD78008KIT780-08KIT
HUD78009780-09
HUD78009KIT780-09KIT
HUD78013780-13
HUD78014780-14
HUD78015780-15
HUD78017KIT780-17KIT
HUD78018780-18
HUD78018KIT780-18KIT
HUD78019780-19
HUD88001KIT880-01KIT
HUD88013KIT880-13KIT
HUD88014KIT880-14KIT
HUD88015KIT880-15KIT
HUD88017KIT880-17KIT

All product manufactured on or after July 9, 2026 are not under scope of the recall and may continue to be used.

Medline is notifying its distributors and customers by email and/or first-class mail and is arranging for credit of all recalled product(s).

Consumers with questions regarding this recall can contact Medline by phone at 866-359-1704 Monday through Friday between the hours of 8am and 5pm CST or [email protected]. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to using this medical device.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.